Deerfield Management Company, L.P. (Series C) Foghorn Therapeutics Inc. Put Options Transaction History
Deerfield Management Company, L.P. (Series C)
- $3.95 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding FHTX
# of Institutions
89Shares Held
36.7MCall Options Held
100Put Options Held
0-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$52.2 Million19.62% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$21.8 Million0.85% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$9.46 Million0.01% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL2.22MShares$9.14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$7.56 Million0.0% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $172M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...